Inflammatory activation biomarker profile after marathon running and its impact on cardiovascular stress in amateur middle-aged male runners

Background. Cardiovascular safety of marathon running middle-aged amateurs remains unclear. We previously hypothesized that transient release of cardiac troponin I (cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), in addition to an acute inflammatory response to exercise, may be the cause.Objectives. To evaluate the effects of running a marathon on inflammatory biomarkers, and its impact on cardiovascular function.Materials and methods. Thirty-three healthy male amateur runners aged >= 50 (mean age: 57 +/- 7 years) were enrolled in the study. Venous blood samples were obtained before the marathon, just after the race, and 2-4 days and 7 days after the marathon. Using novel single molecule counting (SMC) technology, we measured plasma concentrations of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha). White blood cell (WBC) count was measured using a certified hematology analyzer. The results were related to previous analyses on cardiovascular stress and endothelial function biomarkers. Transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR) were used to determine myocardial function.Results. We observed a sharp rise of all studied biomarkers after the race, which subsequently normalized after 2-4 days and stayed within the normal range 7 days after the race. We found no correlation between inflammatory and cardiovascular stress biomarkers. Transthoracic echocardiography and CMR did not show ischemic or inflammatory myocardial damage.Conclusions. Marathon running is associated with a sharp and significant rise in inflammatory and cardiovascular stress biomarkers. We found no connection between immune activation and cardiac biomarker release. Cardiovascular imaging showed no myocardial damage due to ischemia or inflammation.

Automated summary

This study aimed to evaluate the effects of running a marathon on inflammatory biomarkers and cardiovascular function. The results showed a sharp rise of inflammatory and cardiovascular stress biomarkers after the race, but no correlation was found between immune activation and cardiac biomarker release. Cardiovascular imaging also did not show any myocardial damage due to ischemia or inflammation.